---
document_datetime: 2023-09-21 21:03:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tepmetko-epar-all-authorised-presentations_en.pdf
document_name: tepmetko-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6312757
conversion_datetime: 2025-12-24 14:27:05.302355
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form   | Route of administration   | Immediate Packaging              | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|----------------------------------|-------------|
| EU/1/21/1596/001 | TEPMETKO          | 225 mg     | Film-coated tablet    | Oral use                  | Blister (Al/PVC- PE-PVDC-PE-PVC) | 60 tablets  |